1 not yet recruiting. 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Not yet recruiting 1 |
Follow Atezolizumab Plus Bevacizumab: new trials by email Literature Review of Atezolizumab Plus Bevacizumab trials Research Report on Atezolizumab Plus Bevacizumab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Low-Dose Bevacizumab and Atezolizumab Combined With TACE-HAIC in Unresectable Hepatocellular Carcinoma TACE-HAIC + Atezolizumab + Low-dose Bevacizumab - Hepatocellular Carcinoma, Atezolizumab Plus Bevacizumab | Not applicable | Not yet recruiting | Third Affiliated Hospital, Sun Yat-Sen University | 38 | 2026-05-01 | 2026-04-22 |
Adenocarcinoma (1) · Carcinoma (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Liver Diseases (1) · Liver Neoplasms (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Glandular and Epithelial (1)
Bevacizumab (1) · atezolizumab (1)